Assembly Biosciences (ASMB) Accumulated Expenses (2011 - 2021)

Assembly Biosciences' Accumulated Expenses history runs 11 years deep, the most recent figure standing at $3.7 million for Q3 2021.

• In Q3 2021, Accumulated Expenses fell 15.88% year-over-year to $3.7 million; the TTM figure through Sep 2021 stood at $3.7 million (down 15.88% YoY), while the FY2020 annual figure was $4.4 million, down 16.34% from the prior year.
• Accumulated Expenses was $3.7 million for Q3 2021 at Assembly Biosciences, up from $3.7 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $10.1 million in Q1 2019 to a low of $2.8 million in Q2 2019.
• Historically, Accumulated Expenses has averaged $5.2 million across 5 years, with a median of $4.5 million in 2020.
• The sharpest annual moves came in 2017 and 2020: Accumulated Expenses surged 222.84% in 2017, then tumbled 54.31% in 2020.
• A 5-year view of Accumulated Expenses shows it stood at $6.4 million in 2017, then decreased by 26.84% to $4.6 million in 2018, then grew by 14.3% to $5.3 million in 2019, then retreated by 16.34% to $4.4 million in 2020, then retreated by 15.75% to $3.7 million in 2021.
• The last three Accumulated Expenses figures came in at $3.7 million (Q3 2021), $3.7 million (Q2 2021), and $4.3 million (Q1 2021), per Business Quant data.